Keyphrases
Basal Ganglia
12%
Blinking
8%
Blood Flow
8%
Brain Structure
8%
Cerebral Blood Flow
6%
Chronic Tic Disorder
10%
D2 Receptor
17%
Deep Brain Stimulation
6%
Dopamine
19%
Dopamine Agonist
6%
Dopamine D2 Receptor (DRD2)
10%
Flow Response
8%
Focal Dystonia
5%
Functional Magnetic Resonance Imaging
14%
Functional Tics
8%
Healthy Controls
5%
Hippocampal Volume
7%
Image Registration
6%
Levodopa
32%
Magnetic Resonance Imaging
8%
Movement Disorders
8%
Neuroimaging
16%
Neuropsychiatric
5%
Obesity
6%
Parkinson Patients
9%
Parkinson's Disease
45%
Parkinsonism
9%
Pathophysiology
10%
Pediatric
7%
Pharmacodynamics
8%
Pharmacological MRI (phMRI)
7%
Placebo
7%
Positron Emission Tomography
12%
Provisional Tic Disorder
14%
Psychosis
6%
Putamen
12%
Radioligand
6%
Randomized Placebo-controlled Trial
7%
Receptor Binding
11%
Regional Cerebral Blood Flow (rCBF)
16%
Specific Binding
7%
Striatal
10%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
9%
Template Image
7%
Tic Disorders
39%
Tic Severity
9%
Tic Suppression
18%
Tourette Syndrome
100%
Type 1 Diabetes Mellitus (T1DM)
7%
Type I Diabetes
7%
Neuroscience
Agonist
7%
Arterial Spin Labeling
5%
Basal Ganglia
12%
Behavior (Neuroscience)
10%
Body Mass Index
6%
Comorbidity
5%
Deep Brain Stimulation
11%
DNA Template
7%
Dopamine Agonist
7%
Dopamine Receptor D2
8%
Dopaminergic
7%
Dystonia
11%
Fluorine-18
6%
Frontal Lobe
5%
Functional Connectivity
5%
Functional Magnetic Resonance Imaging
18%
Hyperglycemia
5%
Hypoglycemia
6%
In Vivo
7%
L-DOPA
30%
Magnetic Resonance Imaging
13%
Magnetic Resonance Imaging
9%
Parkinson's Disease
49%
Parkinsonism
9%
Placebo
12%
Positron Emission Tomography
15%
Positron Emission Tomography
10%
Putamen
11%
Radioligand
6%
Receptor
13%
Receptor Binding
11%
Stereotypic Movement Disorder
8%
Subthalamic Nucleus
7%
Thalamus
11%
Tic Disorder
47%
Tourette Syndrome
74%